{"id":"https://openalex.org/W223261633","doi":null,"title":"On the role of serotonin2A/2C receptors in the sensitization to cocaine.","display_name":"On the role of serotonin2A/2C receptors in the sensitization to cocaine.","alternate_titles":[],"publication_year":2001,"publication_date":"2001-09-01","ids":{"openalex":"https://openalex.org/W223261633","mag":"223261633","pmid":"https://pubmed.ncbi.nlm.nih.gov/11596864"},"language":"en","primary_location":{"id":"pmid:11596864","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11596864","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of physiology and pharmacology : an official journal of the Polish Physiological Society","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W223261633"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057878334","display_name":"Ma\u0142gorzata Filip","orcid":"https://orcid.org/0000-0002-4321-7942","observed_orcids":["https://orcid.org/0000-0002-4321-7942"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"M Filip","raw_affiliation_strings":["Department of Pharmacology, Institute of Pharmacology Polish Academy of Science, Krakow, Poland. filip@if-pan.krakow.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Institute of Pharmacology Polish Academy of Science, Krakow, Poland. filip@if-pan.krakow.pl","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111883855","display_name":"E. Nowak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Nowak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5088641298","display_name":"Iwona Papla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I Papla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9482,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.68277182,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"52","issue":"3","first_page":"471","last_page":"481"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocaine-sensitization","display_name":"cocaine sensitization","score":0.859000027179718},{"id":"https://openalex.org/keywords/ketanserin","display_name":"ketanserin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/prazosin","display_name":"prazosin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/alpha1-adrenergic-receptors","display_name":"alpha1-adrenoceptors","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":0.5299999713897705},{"id":"https://openalex.org/keywords/chronic-cocaine-exposure","display_name":"chronic cocaine exposure","score":0.4519999921321869}],"concepts":[{"id":"https://openalex.org/C2777785214","wikidata":"https://www.wikidata.org/wiki/Q415997","display_name":"Ketanserin","level":5,"score":0.9673808813095093},{"id":"https://openalex.org/C2780648677","wikidata":"https://www.wikidata.org/wiki/Q425296","display_name":"Prazosin","level":4,"score":0.9053282141685486},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6763869524002075},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5882801413536072},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.499584436416626},{"id":"https://openalex.org/C2776217527","wikidata":"https://www.wikidata.org/wiki/Q944828","display_name":"Sensitization","level":2,"score":0.4991631507873535},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4762135446071625},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.468650758266449},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.43907806277275085},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4190469980239868},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3864479660987854},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3505857288837433},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33676332235336304},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007650","descriptor_name":"Ketanserin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011224","descriptor_name":"Prazosin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044346","descriptor_name":"Receptor, Serotonin, 5-HT1D","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044402","descriptor_name":"Receptor, Serotonin, 5-HT2A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044405","descriptor_name":"Receptor, Serotonin, 5-HT2C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11596864","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11596864","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of physiology and pharmacology : an official journal of the Polish Physiological Society","raw_type":"Journal Article"},{"id":"mag:223261633","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11596864","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2070264479","https://openalex.org/W2005013646","https://openalex.org/W2011506772","https://openalex.org/W2313868102","https://openalex.org/W2128118185","https://openalex.org/W2151277620","https://openalex.org/W2346301012","https://openalex.org/W2033323412","https://openalex.org/W208147820","https://openalex.org/W2163400986"],"abstract_inverted_index":{"Apart":[0],"from":[1],"showing":[2],"involvement":[3],"of":[4,12,19,31,39,106,152,186,233,255,275,281,294,304,311],"dopamine,":[5],"recent":[6],"studies":[7],"also":[8,54,69,298],"indicate":[9,252,301],"a":[10,56,62,103,183,230,253],"role":[11,30,254],"serotonin":[13],"(5-HT)":[14],"in":[15,21,34,43,84,135,158,204,210,261,269,308],"the":[16,24,29,35,113,155,178,187,205,224,226,239,262,270,309],"behavioral":[17,227],"effects":[18],"cocaine":[20,42,81,107,121,132,153,208,234,276,282,312],"rodents.":[22],"In":[23,110,172,219],"present":[25],"study":[26],"we":[27],"investigated":[28],"5-HT2A/2C":[32,256,305],"receptors":[33,67,257],"development":[36],"or":[37,89,93,120,139,143,217,289],"expression":[38,271],"sensitization":[40],"to":[41,207,229,287,300],"rats,":[44],"using":[45],"ketanserin,":[46,244],"an":[47],"antagonist":[48,64],"at":[49,65],"these":[50],"receptors.":[51],"Since":[52,278],"ketanserin":[53,90,140,165],"shows":[55],"high":[57],"affinity":[58],"for":[59,124,291],"alpha1-adrenoceptors,":[60],"prazosin,":[61],"comparative":[63],"those":[66],"was":[68,162,189,202,235,241],"examined.":[70],"Male":[71],"Wistar":[72],"rats":[73,211],"were":[74,115,128],"treated":[75,174,212,221],"repeatedly":[76,175,213,222],"(for":[77],"5":[78,125],"days)":[79],"with":[80,86,118,131,137,176,214,223,243,247],"(10":[82,108,122,133],"mg/kg)":[83,92,123,134,142,146],"combination":[85,136],"either":[87,117],"vehicle,":[88,138],"(1-3":[91,141],"prazosin":[94,144],"(3":[95,145,166],"mg/kg);":[96],"afterwards,":[97],"on":[98,147],"day":[99,148],"10,":[100],"they":[101],"received":[102],"challenge":[104,184,209,231],"dose":[105,185,232],"mg/kg).":[109],"another":[111],"experiment,":[112],"animals":[114,173,220],"given":[116],"vehicle":[119],"days,":[126],"and":[127],"then":[129],"challenged":[130],"10.":[149],"Acute":[150],"administration":[151],"increased":[154],"locomotor":[156,179,264],"activity":[157],"rats;":[159],"that":[160,195],"hyperactivation":[161],"inhibited":[163],"by":[164,170,182,283],"mg/kg),":[167],"but":[168,245],"not":[169,246,259,273],"prazosin.":[171,248],"cocaine,":[177,215],"hyperactivity":[180],"induced":[181],"psychostimulant":[188],"ca.":[190],"2-3":[191],"times":[192],"higher":[193],"than":[194],"after":[196],"its":[197],"first":[198],"administration.":[199],"No":[200],"difference":[201],"observed":[203],"response":[206,228],"ketanserin+cocaine,":[216],"prazosin+cocaine.":[218],"psychostimulant,":[225],"dose-dependently":[236],"decreased":[237],"when":[238],"drug":[240,293],"combined":[242],"The":[249],"above":[250],"findings":[251,297],"(but":[258,272],"alpha1-adrenoceptors)":[260],"acute":[263],"hyperactivity,":[265],"as":[266,268],"well":[267],"development)":[274],"sensitization.":[277],"chronic":[279],"use":[280],"humans":[284],"may":[285],"lead":[286],"psychoses":[288],"craving":[290],"this":[292],"abuse,":[295],"our":[296],"seem":[299],"possible":[302],"importance":[303],"receptor":[306],"antagonists":[307],"therapy":[310],"addiction.":[313]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W223261633","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
